11:25am ET
Health and Healthcare
The Bullish and Bearish Case for Pfizer in 2015
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Companies
/Healthcare
Pfizer Inc
$28.30
▼ $0.27 (−0.95%) today
Markets closed · 6:41am ET
PFE Coverage
Page 67
8:15am ET
Companies and Brands
The Bullish and Bearish Case for Johnson & Johnson in 2015
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
4:01pm ET
Investing
The 4 Stocks That Pushed Friday’s Market to New Highs
thinkstockDecember 26, 2014: Markets opened higher on Friday on a morning when it was difficult to find any market-moving news at all. Energy opened higher but traded about $1 a barrel lower…
11:25am ET
Investing
Great Dividends: Meet the Preliminary 2015 Dogs of the Dow
With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow will look like for the year ahead.
10:35am ET
Health and Healthcare
What a Generic Celebrex Means for Pfizer and for Actavis
While this was generally a known event coming down the pipe, arthritis drug Celebrex now has a generic competitor in America.
4:01pm ET
Investing
The 4 Stocks That Carried the Market on Friday
thinkstockDecember 4, 2014: Markets opened higher on Friday after the federal government released a better-than-expected report on employment. Job gains rose to their highest level since 2012, and aggregate wages rose 0.9%,…
8:25am ET
Investing
2014’s Underperforming Large-Cap Stocks That Could Be 2015 Winners
The U.S. equity market is still a great place to be, and the analysts at Jefferies may have a good plan for where to rotate some 2014 winners and losers.
8:25am ET
Investing
Analyst’s 4 Stocks to Buy With Imminent Catalysts
A new report from Jefferies focuses on four stocks to buy that have impending events that could make a difference for investors.
4:01pm ET
Investing
The 4 Stocks That Lifted the DJIA
thinkstockNovember 25, 2014: Markets opened higher on Tuesday but the gains were small heading into the long weekend. The second reading on U.S. GDP was higher than expected, but that was not…
9:10am ET
Companies and Brands
Companies Spending the Most on R&D
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
12:40pm ET
Health and Healthcare
Pain Therapeutics and Durect Stung by Pfizer Move
Durect and Pain Therapeutics have been stung by Pfizer's decision to discontinue to develop Remoxy.
Chris Lange 4:01pm ET
Investing
The 4 DJIA Stocks That Boosted the Market
thinkstockOctober 24, 2014: Markets opened slightly higher on Friday, and following a short trip below the break-even line, marched higher and appear headed to close up for the second consecutive day. With…
8:05am ET
Health and Healthcare
Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra
Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."
4:01pm ET
Investing
The 4 Stocks That Held the DJIA Down
thinkstockOctober 16, 2014: Markets opened lower on Thursday following a sharp drop in crude oil prices overnight and a better-than-expected report on new claims for jobless benefits. St. Louis Fed President James…
9:30am ET
Investing
Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks
Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.